Your browser doesn't support javascript.
loading
Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance).
Fuchs, M A; Yuan, C; Sato, K; Niedzwiecki, D; Ye, X; Saltz, L B; Mayer, R J; Mowat, R B; Whittom, R; Hantel, A; Benson, A; Atienza, D; Messino, M; Kindler, H; Venook, A; Innocenti, F; Warren, R S; Bertagnolli, M M; Ogino, S; Giovannucci, E L; Horvath, E; Meyerhardt, J A; Ng, K.
Affiliation
  • Fuchs MA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston.
  • Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston.
  • Sato K; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston.
  • Niedzwiecki D; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston.
  • Ye X; Alliance Statistics and Data Center, Duke University Medical Center, Durham.
  • Saltz LB; Alliance Statistics and Data Center, Duke University Medical Center, Durham.
  • Mayer RJ; Memorial Sloan-Kettering Cancer Center, New York.
  • Mowat RB; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston.
  • Whittom R; Toledo Community Hospital Oncology Program, Toledo, USA.
  • Hantel A; Hôpital du Sacré-Coeur de Montréal, Montreal, Canada.
  • Benson A; Edward Cancer Center, Naperville.
  • Atienza D; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago.
  • Messino M; Virginia Oncology Associates, Norfolk.
  • Kindler H; Southeast Cancer Control Consortium, Mission Hospitals-Memorial Campus, Asheville.
  • Venook A; University of Chicago, Chicago.
  • Innocenti F; University of California at San Francisco Comprehensive Cancer Center, San Francisco.
  • Warren RS; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill.
  • Bertagnolli MM; University of California at San Francisco Comprehensive Cancer Center, San Francisco.
  • Ogino S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston.
  • Giovannucci EL; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston.
  • Horvath E; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston.
  • Meyerhardt JA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston.
  • Ng K; Division of MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston.
Ann Oncol ; 28(6): 1359-1367, 2017 Jun 01.
Article in En | MEDLINE | ID: mdl-28327908
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitamin D / Colonic Neoplasms / Neoplasm Recurrence, Local Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitamin D / Colonic Neoplasms / Neoplasm Recurrence, Local Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Type: Article